Abstract
OA-10 Four years treatment with zoledronic acid is superior to two years in protection against progressive bone disease in multiple myeloma
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have